• Blog

Cancer care has long been delivered via fragmented systems—oncologists in one location, chemotherapy infusions in another, support services scattered. But a shift toward integrated cancer care—where oncology practices and infusion centers are more tightly aligned—is driving improvements in efficiency, patient experience, and outcomes.

Key Drivers of Integration

• Multidisciplinary Teams: Oncology is increasingly supported by pharmacists, nurse practitioners, physician assistants, and allied health professionals who intervene regularly. Studies show that when such teams manage treatment‐related adverse events (TRAEs) in infusion settings, both the rates and severity of side‐effects decline.
  
• Process Efficiency: Infusion centers that optimize patient flow, minimize wait times, streamline chemo premixing, and reduce chair occupancy times significantly improve throughput without sacrificing safety. The NCCN Infusion Efficiency Workgroup, for example, found large variation in wait times (25–102 minutes) and infusion chair utilization across centers, indicating room for standardization and improvement.
  
• Shifting Care to Outpatient Settings: Bringing more chemotherapy or complex infusions to outpatient or dedicated infusion suites (close to inpatient units) reduces hospital length of stay (LOS), lowers costs, and often improves patient satisfaction. One quality improvement initiative showed reducing LOS and start‐times for chemotherapy by situating an integrated outpatient infusion suite near inpatient operations.
  

Outcomes Improvements

• Reduced incidence of severe side effects and better management of toxicities due to earlier detection and intervention by multidisciplinary staff.
  
• Faster treatment starts and shorter inpatient stays, which both relieve burden on hospital resources and improve quality metrics.
  
• Better patient experience—less waiting, fewer logistical obstacles (travel, scheduling), more cohesive communication.
  

Challenges & Best Practices

• Ensuring drug premixing protocols and safety standards are robust so that patient safety is never compromised in drive for speed.
  
• Appropriate staffing models so that expertise is present (e.g. specialized nurses and local medical oversight in infusion centers).
  
• Monitoring throughput metrics (chair utilization, wait times, start times) and investing in facility design for patient comfort and flow.
  
• Payment and reimbursement models must align: if insurers or payers reward integrated outpatient care or penalize unnecessary admissions, integration is more sustainable.
  

The Bloom Organization

The Bloom Organization has established itself as a leader in healthcare investment banking, particularly in structuring and advising complex transactions in cancer care, oncology services, and infusion centers. Their team has successfully guided providers and investors to capitalize on integration opportunities—helping practices sell or merge, facilitating capital raises, and structuring deals to align incentives across multiple care settings. This focus has enabled many clients to scale, improve patient outcomes, and enhance valuations in activities tied to oncology and infusion services.